Skip to main content

MoneyWorks4Me

The turnover for the September 2026 quarter moved up 62.76% to Rs. 1811.68 millions as compared to Rs. 1113.13 millions during the year-ago period.The Net Profit of the company reported a remarkable increase of 105.63% to Rs. 290.25  millions  from Rs. 141.15 millions in previous same quarter.Operating profit for the quarter ended September 2026 rose to 505.69 millions as compared to 262.48 millions of corresponding quarter ended September 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 1811.68 1113.13 62.76 3435.20 2227.92 54.19 5030.59 3701.97 35.89
Other Income 7.71 8.97 -14.05 13.94 12.73 9.51 28.59 19.20 48.91
PBIDT 505.69 262.48 92.66 922.13 508.09 81.49 1210.88 823.64 47.02
Interest 29.95 28.42 5.38 56.56 56.02 0.96 109.70 98.78 11.05
PBDT 475.74 234.06 103.26 865.57 452.07 91.47 1092.89 724.86 50.77
Depreciation 53.58 49.56 8.11 103.50 97.16 6.53 197.94 182.58 8.41
PBT 422.16 184.50 128.81 762.07 354.91 114.72 894.95 542.28 65.03
TAX 131.91 43.35 204.29 215.56 94.43 128.27 221.46 143.38 54.46
Deferred Tax 22.00 1.84 1095.65 19.15 9.33 105.25 -8.87 -15.89 -44.18
PAT 290.25 141.15 105.63 546.51 260.48 109.81 673.49 398.90 68.84
Equity 103.76 103.76 0.00 103.76 103.76 0.00 103.76 103.76 0.00
PBIDTM(%) 27.91 23.58 18.37 26.84 22.81 17.71 24.07 22.25 8.19
Peers
Company Name CMP
Sun Pharma. Inds. 1897.75
Dr. Reddys Labs. 1389.45
Cipla 1411.95
Lupin 1987.70
Zydus Lifesciences 1198.30
View more..